We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-13.33%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$98.7B
AUM Growth
-$13.4B
Cap. Flow
+$3.55B
Cap. Flow %
3.6%
Top 10 Hldgs %
17.21%
Holding
8,079
New
273
Increased
3,486
Reduced
3,341
Closed
357

Sector Composition

Rank Sector Weight
1 Technology 5.78%
2 Financials 5.08%
3 Healthcare 4.24%
4 Consumer Discretionary 4.16%
5 Energy 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPH
7301
CALL
DELISTED
Tri Pointe Homes
TPH
$4K ﹤0.01%
400
-2,600
-87% -$30.7K
VANI icon
7302
Vivani Medical
VANI
$112M
$4K ﹤0.01%
166
VST icon
7303
PUT
Vistra
VST
$53B
$4K ﹤0.01%
195
WTMF icon
7304
WisdomTree Managed Futures Strategy Fund
WTMF
$244M
$4K ﹤0.01%
103
-294
-74% -$11.8K
XENE icon
7305
Xenon Pharmaceuticals
XENE
$6.36B
$4K ﹤0.01%
600
SBOW
7306
DELISTED
SilverBow Resources, Inc.
SBOW
$4K ﹤0.01%
166
-1,579
-90% -$40.7K
CSML
7307
DELISTED
IndexIQ ETF Trust IQ U.S. Small Cap ETF
CSML
$4K ﹤0.01%
170
XWEB
7308
DELISTED
SPDR S&P Internet ETF
XWEB
$4K ﹤0.01%
49
-164
-77% -$13.8K
SFUN
7309
CALL
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$4K ﹤0.01%
58
-2
-3% -$189
LAIX
7310
DELISTED
LAIX Inc. American Depositary Shares, each representing fourteen Class A Ordinary Shares
LAIX
$4K ﹤0.01%
+33
New +$4.46K
VTA
7311
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$4K ﹤0.01%
400
SWI
7312
DELISTED
SolarWinds Corporation Common Stock
SWI
$4K ﹤0.01%
+269
New +$4.22K
CNST
7313
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$4K ﹤0.01%
1,063
-66
-6% -$398
BXG
7314
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
$4K ﹤0.01%
279
-1,763
-86% -$23.7K
MIK
7315
PUT
DELISTED
Michaels Stores, Inc
MIK
$4K ﹤0.01%
+300
New +$4.76K
MLPI
7316
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
$4K ﹤0.01%
+179
New +$3.94K
BQH
7317
DELISTED
BlackRock New York Municipal Bond Trust
BQH
$4K ﹤0.01%
350
DNI
7318
DELISTED
Dividend and Income Fund
DNI
$4K ﹤0.01%
400
AGFSW
7319
CALL
DELISTED
AgroFresh Solutions Inc Warrants
AGFSW
$4K ﹤0.01%
22,500
CRR
7320
CALL
DELISTED
Carbo Ceramics Inc.
CRR
$4K ﹤0.01%
1,100
-2,100
-66% -$10.5K
HOS
7321
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$4K ﹤0.01%
2,354
+454
+24% +$1.59K
VSI
7322
CALL
DELISTED
Vitamin Shoppe Inc.
VSI
$4K ﹤0.01%
800
-4,600
-85% -$34.5K
BID
7323
CALL
DELISTED
Sotheby's
BID
$4K ﹤0.01%
100
-6,400
-98% -$261K
GNCA
7324
DELISTED
Genocea Biosciences, Inc.
GNCA
$4K ﹤0.01%
1,625
NAVB
7325
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$4K ﹤0.01%
2,040

Similar funds

Citigroup's Q4 2018 Portfolio in Review

As of Q4 2018, Citigroup held 8,079 positions worth $98.7B, down 12% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citigroup deployed $3.55B of net new capital in Q4 2018, opening 273 new positions and adding to 3,486 existing holdings. Its largest new stake was Takeda Pharmaceutical: 6,548,306 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 5.8% of assets, up from 5.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.83B trimmed.

  • Citigroup's largest Q4 2018 buy was Takeda Pharmaceutical: 6,548,306 shares worth $113M.
  • Citigroup added most to Energy Transfer Partners in Q4 2018, an estimated $560M increase.
  • Citigroup's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $1.83B.
  • Citigroup fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $677M.
  • Citigroup's ten largest holdings make up 17% of its $98.7B portfolio in Q4 2018.
  • Citigroup opened 273 new positions and closed 357 in Q4 2018.
  • Citigroup's portfolio value fell 12% quarter-over-quarter to $98.7B.

Based on Citigroup's 13F filing for Q4 2018, filed 12 Feb 2019.